We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Anaphore Announces Acquisition of RuiYi for GPCR Biologics Drug Discovery Platform

News   Mar 26, 2012

 
Anaphore Announces Acquisition of RuiYi for GPCR Biologics Drug Discovery Platform
 
 
Advertisement
 

RELATED ARTICLES

Safer and More Efficient Method To Deliver Gene Therapy

News

Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination.

READ MORE

Steroids May Offer COVID-19 Treatment Strategy in Patients With Endocrine Disorders

News

According to a new review, people with endocrine disorders may see their condition worsen as a result of COVID-19. The study authors note that mortality was shown to be lower in severely-ill patients with COVID-19 treated with the steroid dexamethasone.

READ MORE

Controlled Human Infection Models for SARS-CoV-2 Vaccine Development

News

Infecting some volunteers with COVID-19 may provide valuable insights for future rounds of vaccine testing, but would require very strict controls, argues a group of infectious disease experts in the New England Journal of Medicine.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE